New York, NY – November 13, 2018 - InvestorsHub NewsWire -- Puration, Inc. (PURA) announced recently its Q3 financial report for the period ending September 30, 2018 would be filed early in order to facilitate a timely stock dividend declaration right after the Q3 filing.  StockTA.com has rated PURA as BULLISH today based on candlestick analysis.  The Q3 report is likely to be on the extraordinarily positive side given the company’s sales have ramped up this year compared to last.  In the previous quarter, the company reported 600% growth compared to the same period for the previous year.  The company recently spun of its cannabis cultivation business to Nouveau Life Pharmaceuticals, Inc. (NOUV) in a deal that included a dividend of NOUV stock to PURA shareholders.  PURA has recently announced working closely with NOUV to be ready for officially declaring the anticipated dividend by November 15th, 2018 with planned date of record within the following 30 days.  Goldman Small Cap Research issued a speculative BUY and $0.25 PPS Target on October 10th.  The PURA PPS hit $0.25 and then snapped back and has steadily been trading healthy volume in the $0.09 - $0.10 range. With a strong Q3 report and a dividend declaration, PURA could see a climb back to the Analyst sustaniend recommendation of a $0.25 Target PPS. 

DISCLAIMER: NextBigTicker.com (NBT)is a third party publisher and news dissemination service provider. NBT is NOT affiliated in any manner with any company mentioned herein. NBT is news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. NBT's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release or opinion of the writer. NBT is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. NBT has not been compensated for this release and HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

Disclaimer/Safe Harbor:

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur.

Source: www.nextbigticker.com
 

Nouveau Life Pharmaceuti... (PK) (USOTC:NOUV)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Nouveau Life Pharmaceuti... (PK) Charts.
Nouveau Life Pharmaceuti... (PK) (USOTC:NOUV)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Nouveau Life Pharmaceuti... (PK) Charts.